Dr. Roth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 NW 14th st
Room 813
Miami, FL 33136Phone+1 305-355-5000Fax+1 305-243-8160
Education & Training
- University of Miami/Jackson Health SystemFellowship, Nephrology, 1980 - 1982
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1977 - 1980
- State University of New York Downstate Medical Center College of MedicineClass of 1977
- State University of New YorkB.S., Chemistry, 1973
Certifications & Licensure
- FL State Medical License 1978 - 2025
- FL State Medical License 1980 - 2025
- NJ State Medical License 1949 - 2007
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Attending of the Year Katz Family Division of Nephrology and Hypertension, 2017
- Mentor of the Year Division of Nephrology and Hypertension, 2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Join now to see all
Publications & Presentations
PubMed
- 64 citationsAn Epidemiologic Study of Early Renal Replacement Therapy after Orthotopic Liver TransplantationGabriel Contreras, Galo Garces, Andrew A. Quartin, Cynthia M. Cely, Mark A. LaGatta
Journal of the American Society of Nephrology. 2002-01-01 - 10 citationsBenefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reapp...George W Burke 3rd, Jayanthi Chandar, Junichiro Sageshima, Mariella Ortigosa-Goggins, Pooja Amarapurkar
Pediatric Nephrology. 2023-01-01 - 66 citationsElbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life ...Annette Bruchfeld, David Roth, Paul J. Martin, David R. Nelson, Stanislas Pol
The Lancet. Gastroenterology & Hepatology. 2017-08-01
Journal Articles
- Treatment and management options for the hepatitis C virus infected kidney transplant candidateDejman A, Ladino M, Roth D, Hemodial Int, 1/22/2018
- End stage kidney disease and the treatment of hepatitis C virus infectionPagan J, Ladino M, Roth D, Current Hepatology Reports, 1/1/2018
- Clinical trials: Treatment of HCV infected patients with advanced kidney diseaseLadino M, Roth D, Nat Rev Nephrol, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The rat with untreated diabetes mellitus: A new model for studying drug-induced nephrotoxicity. Presented at the International Symposium on NephrotoxicityVaamonde C., Teixeria R.B., Morales J., Roth D., Kelly J., Alpert H., and Pardo V, University of Surrey Guildford, England, 1/1/1981
Lectures
- HCV Infection in the ESRD PatientOrlando, FL - 1/16/2018
- The View from 10,000 feet: A Roadmap for the Nephrologist to take charge of their patients with HCV infectionAustin, TX - 1/12/2018
- Chronic HCV and CKD: A Complex CombinationSantiago, Chile - 1/30/2017
- Join now to see all
Press Mentions
- The Lifesaving Potential of Less Than Perfect Donor KidneysDecember 17th, 2020
- The National Kidney Foundation Releases Commentary on Hepatitis C Guidelines for CliniciansApril 9th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: